Search results with tag "Programmatic challenges of dose tapering"

Programmatic Challenges of Dose Tapering Using SAS®

Programmatic Challenges of Dose Tapering Using SAS® Iuliana Barbalau, Santen Inc., Emeryville, CA Chen Shi, Santen Inc., Emeryville, CA Yang Yang, Santen Inc., Emeryville, CA ABSTRACT: In a good clinical study, statisticians and various stakeholders are interested in assessing and isolating the effect of non-study drugs.

  Challenges, Dose, Programmatic, Tapering, Programmatic challenges of dose tapering